MedPath

Comparative study of various antihistamines in the treatment of urticaria

Phase 4
Conditions
Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
Registration Number
CTRI/2022/11/047129
Lead Sponsor
Meenakshi medical college hospital and research institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patients with diagnosis of urticaria (acute/chronic)

2)Patients for whom documented consent has been obtained regarding their voluntary participation in this clinical study

3) Patients aged 18 years or older at the time that they provide consent.

4) Patient agrees not to take other treatments than those provided in the study.

Exclusion Criteria

1)pregnant and lactating females

2)patients who are immunocompromised due to disease or drugs

3) Patients with pruritis caused due to other cutaneous skin disorders.

4) Patients with known hypersensitivity to antihistamines.

5) Known case of Bronchial asthama / COPD.

6) Patients with urticaria presenting with systemic signs/symptoms

7) Patients with urticaria and angio oedema

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare efficacy of three group of antihistamineTimepoint: To compare efficacy of three group of antihistamine
Secondary Outcome Measures
NameTimeMethod
To note down side effectsTimepoint: At baseline and after 2 weeks
© Copyright 2025. All Rights Reserved by MedPath